Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Henderson Lori M.. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Henderson Lori M. reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:MRNA / Moderna, Inc. General Counsel and Secretary 328,352
US:AMRI / Albany Molecular Research, Inc. SVP, Secretary & Gen Counsel 0
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Henderson Lori M.. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Henderson Lori M. conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2021-05-28 2021-05-27 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 328,352 -1.97
2021-05-28 2021-05-27 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 174.20 -1,149,720 156,954
2021-05-28 2021-05-27 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 14.85 98,010 111,390
2021-05-27 2021-05-25 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 334,952 -1.93
2021-05-27 2021-05-25 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 166.58 -1,099,428 150,089
2021-05-27 2021-05-25 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 14.85 98,010 111,390
2021-05-21 2021-05-20 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 341,552 -1.90
2021-05-21 2021-05-20 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 159.92 -1,055,472 144,088
2021-05-21 2021-05-20 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 14.85 98,010 111,390
2021-05-20 2021-05-18 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 348,152 -1.86
2021-05-20 2021-05-18 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 160.16 -1,057,056 144,304
2021-05-20 2021-05-18 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 14.85 98,010 111,390
2021-05-14 2021-05-13 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 354,752 -1.83
2021-05-14 2021-05-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 152.60 -1,007,160 137,493
2021-05-14 2021-05-13 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 14.85 98,010 111,390
2021-05-13 2021-05-11 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,170 361,352 -1.68
2021-05-13 2021-05-11 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -430 93,046 -0.46
2021-05-13 2021-05-11 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 151.31 -998,646 136,330
2021-05-13 2021-05-11 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,170 7,501 463.56 14.85 91,624 111,390
2021-05-13 2021-05-11 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 430 1,331 47.72 20.93 9,000 27,858
2021-05-07 2021-05-06 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 93,476 -6.59
2021-05-07 2021-05-06 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 147.82 -975,612 133,186
2021-05-07 2021-05-06 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-05-06 2021-05-04 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 100,076 -6.19
2021-05-06 2021-05-04 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 185.25 -1,222,650 166,910
2021-05-06 2021-05-04 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-30 2021-04-29 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 106,676 -5.83
2021-04-30 2021-04-29 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 182.49 -1,204,434 164,423
2021-04-30 2021-04-29 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-29 2021-04-27 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 113,276 -5.51
2021-04-29 2021-04-27 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 178.29 -1,176,714 160,639
2021-04-29 2021-04-27 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-23 2021-04-22 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 119,876 -5.22
2021-04-23 2021-04-22 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 168.26 -1,110,516 151,602
2021-04-23 2021-04-22 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-22 2021-04-20 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 126,476 -4.96
2021-04-22 2021-04-20 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 160.32 -1,058,112 144,448
2021-04-22 2021-04-20 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-16 2021-04-15 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 133,076 -4.73
2021-04-16 2021-04-15 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 158.76 -1,047,816 143,043
2021-04-16 2021-04-15 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-14 2021-04-13 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 139,676 -4.51
2021-04-14 2021-04-13 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 146.62 -967,692 132,105
2021-04-14 2021-04-13 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-09 2021-04-08 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 146,276 -4.32
2021-04-09 2021-04-08 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 132.85 -876,810 119,698
2021-04-09 2021-04-08 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-08 2021-04-06 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 152,876 -4.14
2021-04-08 2021-04-06 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 130.01 -858,066 117,139
2021-04-08 2021-04-06 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-02 2021-04-01 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 159,476 -3.97
2021-04-02 2021-04-01 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 132.51 -874,566 119,392
2021-04-02 2021-04-01 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-04-01 2021-03-30 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 166,076 -3.82
2021-04-01 2021-03-30 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 123.30 -813,780 111,093
2021-04-01 2021-03-30 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-03-26 2021-03-25 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 172,676 -3.68
2021-03-26 2021-03-25 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 126.88 -837,408 114,319
2021-03-26 2021-03-25 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-03-25 2021-03-23 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 179,276 -3.55
2021-03-25 2021-03-23 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 145.55 -960,630 131,141
2021-03-25 2021-03-23 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 20.93 138,138 156,996
2021-03-19 2021-03-18 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -216 185,876 -0.12
2021-03-19 2021-03-18 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,384 118,155 -5.13
2021-03-19 2021-03-18 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 144.39 -952,974 130,095
2021-03-19 2021-03-18 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 216 7,501 2.96 20.93 4,521 156,996
2021-03-19 2021-03-18 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,384 7,285 708.55 25.93 165,537 188,900
2021-03-18 2021-03-16 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 124,539 -5.03
2021-03-18 2021-03-16 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 148.50 -980,100 133,798
2021-03-18 2021-03-16 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 25.93 171,138 194,501
2021-03-12 2021-03-11 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 131,139 -4.79
2021-03-12 2021-03-11 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 133.29 -879,714 120,094
2021-03-12 2021-03-11 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 25.93 171,138 194,501
2021-03-10 2021-03-09 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 137,739 -4.57
2021-03-10 2021-03-09 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 127.11 -838,926 114,526
2021-03-10 2021-03-09 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 25.93 171,138 194,501
2021-03-05 2021-03-04 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 144,339 -4.37
2021-03-05 2021-03-04 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 128.58 -848,628 115,851
2021-03-05 2021-03-04 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 25.93 171,138 194,501
2021-03-04 2021-03-02 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,600 150,939 -4.19
2021-03-04 2021-03-02 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -6,600 901 -87.99 153.77 -1,014,882 138,547
2021-03-04 2021-03-02 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 6,600 7,501 732.52 25.93 171,138 194,501
2020-10-23 2020-10-21 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -32,000 367,522 -8.01
2020-10-23 2020-10-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -700 681 -50.69 71.39 -49,973 48,617
2020-10-23 2020-10-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -15,455 1,381 -91.80 70.56 -1,090,505 97,443
2020-10-23 2020-10-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -14,148 16,836 -45.66 69.84 -988,096 1,175,826
2020-10-23 2020-10-21 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -1,697 30,984 -5.19 68.70 -116,584 2,128,601
2020-10-23 2020-10-21 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 32,000 32,681 4,698.97 14.85 475,200 485,313
2020-06-19 2020-06-18 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -64,000 399,522 -13.81
2020-06-19 2020-06-18 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -64,000 681 -98.95 63.03 -4,033,920 42,923
2020-06-19 2020-06-18 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 64,000 64,681 9,397.94 14.85 950,400 960,513
2020-06-04 2020-05-20 4/A MRNA Moderna, Inc.
Common Stock
S - Sale X -64,000 0 -100.00 70.00 -4,480,000
2020-05-22 2020-05-20 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -64,000 463,522 -12.13
2020-05-22 2020-05-20 4 MRNA Moderna, Inc.
Common Stock
S - Sale X -64,000 0 -100.00 70.00 -4,480,000
2020-05-22 2020-05-20 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 64,000 64,000 14.85 950,400 950,400
2020-03-03 2020-02-28 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 157,539 157,539
2019-03-11 2019-03-08 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 186,092 186,092
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -44,251 0 -100.00 3.34 -147,798
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -29,066 0 -100.00 5.98 -173,815
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -22,893 0 -100.00 4.70 -107,597
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -29,167 0 -100.00 11.32 -330,170
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -4,375 0 -100.00 15.76 -68,950
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -4,375 0 -100.00 15.76 -68,950
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -4,375 0 -100.00 15.76 -68,950
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -17,500 0 -100.00 15.76 -275,800
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -17,500 0 -100.00 18.82 -329,350
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -4,375 0 -100.00 18.82 -82,338
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -4,375 0 -100.00 18.82 -82,338
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -17,500 0 -100.00 16.50 -288,750
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
D - Sale to Issuer -50,000 0 -100.00 16.88 -844,000
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
D - Sale to Issuer -66,717 0 -100.00 21.75 -1,451,095
2017-09-05 2017-08-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 4,722 66,717 7.62
2017-09-05 2017-08-28 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
G - Gift -9,857 52,138 -15.90
2017-03-06 2017-03-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -432 61,995 -0.69 14.52 -6,273 900,167
2017-02-10 2017-02-08 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
A - Award 44,251 44,251
2017-02-10 2017-02-08 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 6,747 62,427 12.12
2017-02-10 2017-02-08 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 8,990 55,680 19.25
2017-02-07 2017-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -504 46,690 -1.07 18.52 -9,334 864,699
2017-02-07 2017-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -674 47,194 -1.41 18.52 -12,482 874,033
2017-02-07 2017-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -2,363 47,868 -4.70 18.52 -43,763 886,515
2017-02-01 2017-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -553 50,231 -1.09 18.11 -10,015 909,683
2017-02-01 2017-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -553 50,231 -1.09 18.11 -10,015 909,683
2016-11-17 2016-11-16 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale -6,000 51,337 -10.46 17.00 -102,000 872,729
2016-11-03 2016-11-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -409 57,337 -0.71 15.09 -6,172 865,215
2016-03-04 2016-03-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -421 57,746 -0.72 15.33 -6,454 885,246
2016-02-19 2016-02-17 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
D - Sale to Issuer -1,459 58,167 -2.45
2016-02-19 2016-02-17 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -463 59,626 -0.77 15.37 -7,116 916,452
2016-02-08 2016-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
A - Award 29,066 29,066 15.77 458,371 458,371
2016-02-08 2016-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 12,682 60,089 26.75 15.77 199,995 947,604
2016-02-05 2016-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -684 47,407 -1.42 16.16 -11,053 766,097
2016-02-01 2016-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -554 48,091 -1.14 15.97 -8,847 768,013
2016-02-01 2016-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -554 48,091 -1.14 15.97 -8,847 768,013
2015-11-04 2015-11-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 5,000 49,199 11.31 19.16 95,800 942,653
2015-06-04 2015-06-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
D - Sale to Issuer -1,459 44,199 -3.20
2015-06-04 2015-06-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -476 45,658 -1.03
2015-03-04 2015-03-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
A - Award 22,893 22,893 17.05 390,326 390,326
2015-03-04 2015-03-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 10,588 46,134 29.79 17.05 180,525 786,585
2015-02-19 2015-02-17 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
D - Sale to Issuer -1,458 35,546 -3.94
2015-02-19 2015-02-17 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -464 37,004 -1.24
2015-02-06 2015-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -1,582 37,468 -4.05
2015-02-03 2015-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
D - Sale to Issuer -1,459 39,050 -3.60
2015-02-03 2015-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -554 40,509 -1.35
2014-10-01 2014-10-01 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale X -1,000 41,063 -2.38 21.48 -21,480 882,033
2014-09-03 2014-09-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale X -2,500 42,063 -5.61 19.56 -48,900 822,752
2014-08-13 2014-08-12 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to Purchase Common Stock
M - Exercise 30,000 50,000 150.00 4.87 146,100 243,500
2014-08-13 2014-08-12 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale -30,000 44,563 -40.23 19.05 -571,500 848,925
2014-08-13 2014-08-12 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
M - Exercise 30,000 74,563 67.32 4.87 146,100 363,122
2014-08-01 2014-08-01 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale X -2,500 44,563 -5.31 18.56 -46,400 827,089
2014-07-02 2014-07-01 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale X -2,500 47,063 -5.04 20.62 -51,550 970,439
2014-06-04 2014-06-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -476 49,563 -0.95
2014-06-04 2014-06-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
D - Sale to Issuer -1,458 50,039 -2.83
2014-06-04 2014-06-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale X -2,500 51,497 -4.63 16.32 -40,800 840,431
2014-05-01 2014-05-01 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale X -2,500 53,997 -4.43 15.73 -39,325 849,373
2014-04-02 2014-04-01 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
S - Sale X -2,500 56,497 -4.24 18.74 -46,850 1,058,754
2014-02-19 2014-02-17 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -1,038 58,997 -1.73
2014-02-06 2014-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock
A - Award 29,167 29,167 10.43 304,212 304,212
2014-02-06 2014-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 14,584 60,035 32.09 10.43 152,111 626,165
2014-02-06 2014-02-04 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -948 45,451 -2.04
2014-02-04 2014-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -1,106 46,399 -2.33
2013-06-04 2013-06-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
F - Taxes -477 47,505 -0.99
2013-06-04 2013-06-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
D - Sale to Issuer -1,458 47,982 -2.95
2013-02-04 2013-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock
A - Award 35,000 35,000 5.99 209,650 209,650
2013-02-04 2013-01-31 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 11,666 49,440 30.88 5.99 69,879 296,146
2012-06-12 2012-06-02 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
D - Sale to Issuer -1,458 37,774 -3.72
2012-02-21 2012-02-17 4 AMRI ALBANY MOLECULAR RESEARCH INC
Option to purchase Common Stock
A - Award 35,000 35,000 2.93 102,550 102,550
2012-02-21 2012-02-17 4 AMRI ALBANY MOLECULAR RESEARCH INC
Common Stock
A - Award 11,666 39,232 42.32 2.93 34,181 114,950
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)